Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

VBH

- PMLiVE

Novartis moves swiftly with lymphoma filing for CAR-T Kymriah

Will go up against Kite Pharma's Yescarta if approved

- PMLiVE

Novartis to buy French radiopharma specialist AAA for $3.9bn

Deal will strengthen its cancer therapy business, says Swiss pharma group

- PMLiVE

The cultural construction of illness

Why understanding this concept is  essential for pharmaceutical marketers

Novartis Gehry Building

Alcon spin-out more likely but not imminent, says Novartis

A stand-alone company could offer “additional shareholder value”

- PMLiVE

Patient disengagement

Understanding the why

- PMLiVE

The patient’s world is ‘messy’

And therein lies the value for pharma

Price matters

But so does innovation

- PMLiVE

After failing to repeal Obamacare, Trump tries another tack

US president signs executive order encouraging cheaper policies with fewer benefits

- PMLiVE

Attracting doctors to low-demand specialties

A role for industry?

- PMLiVE

Novartis gets EU nod for leukaemia drug Rydapt

The FLT3 inhibitor adds to its US approval in AML

- PMLiVE

Roche faces prospect of second Rituxan biosimilar in US

FDA begins its review of Sandoz's version of the immunotherapy treatment

Novartis looks outside pharma for digital transformation

Appoints former Sainsbury's Argos executive Bertrand Bodson

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links